Market by Solution, Technology, Type, Industry Vertical, and Country Outlook | Forecast 2024-2032
As per Triton Market Research’s report, the artificial intelligence (AI) in healthcare market in Latin America is estimated to garner a CAGR of 38.16% during the forecast period 2024-2032.
The countries studied in the region include:
• Brazil
• Mexico
• Rest of Latin America
AI technology in healthcare lowers
costs and lightens the workload for professionals. It aids clinical decisions,
streamlines workflows, and predicts health outcomes. Latin America anticipates
growth in AI-driven telehealth services and collaborations among healthcare
facilities, which will further widen the growth of the AI in healthcare market.
Brazil dominates the market with the
majority of the share. The country is making significant strides in integrating AI into
its healthcare sector, committed to fostering a favorable environment for the
responsible advancement of AI technology. In April 2021, the Brazilian
government unveiled the National Strategy for Artificial Intelligence (EBIA).
This strategy harnessed Brazil’s technological prowess and innovation to tackle
challenges and forge fresh opportunities within the innovation landscape.
Artificial intelligence (AI) has
made significant strides in Brazil’s healthcare sector. At Fluminense Federal
University (UFF) in Rio, researchers are employing AI in various innovative
projects. One such project involves the utilization of thermography image
processing to screen for breast cancer, while another focuses on using AI to
detect mild cognitive impairment (MCI) as a preventative measure against
dementia. These initiatives highlight the growing role of AI in enhancing
healthcare outcomes and addressing critical medical challenges.
Numerous hospitals across Mexico are
integrating Hospital Information Systems (HIS), employing AI algorithms to
facilitate medical decisions, resource allocation, and predictive modeling.
Additionally, AI-driven medical imaging technologies, including computer-aided
diagnosis (CAD) systems, are on the rise in Mexico to assist in disease
detection and diagnosis. This further accelerates the progression of the AI in
healthcare market.
Artificial Intelligence (AI) is a
field within computer science focused on replicating intelligent actions in
machines. AI systems can mimic human behavior, playing a significant role in
diverse industries, including healthcare. These systems provide comprehensive
services. In healthcare, AI providers offer services like telehealth and
technical support to address any issues that may arise with the technology.
The market is broadly segmented into solution, type, technology,
and industry vertical. Based on the solution, it is divided into services, hardware, and
software.
The major companies listed in the market report include Medtronic
Plc, NVIDIA Corporation, Oncora Medical, Microsoft Corporation, and Recursion
Pharmaceuticals Inc.
Medtronic Plc is a pioneering
medical technology company. It is involved in designing, developing,
manufacturing, and marketing a wide range of medical devices and solutions.
These encompass treatments for diverse conditions such as heart valve disorders,
heart failure, and coronary artery diseases, as well as neurological, spinal,
musculoskeletal, and ear, nose, and throat ailments. The company’s clientele
includes hospitals, healthcare providers, clinics, and various institutions
across multiple regions, including Latin America.
KEY DELIVERABLES OF THE REPORT:
●
Market CAGR during the forecasting years 2024-2032
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the artificial
intelligence (AI) in healthcare
market revenue growth in Latin America and its
influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape and Porter’s
Five Forces
●
A wide-ranging study of factors that will challenge the Latin
America artificial intelligence (AI) in healthcare market’s growth
during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. PORTER’S
FIVE FORCES ANALYSIS
2.1.1. BUYERS
POWER
2.1.2. SUPPLIERS
POWER
2.1.3. SUBSTITUTION
2.1.4. NEW
ENTRANTS
2.1.5. INDUSTRY
RIVALRY
2.2. MARKET
MATURITY ANALYSIS
2.3. VALUE
CHAIN ANALYSIS
2.3.1. DATA
WAREHOUSE
2.3.2. ARTIFICIAL
INTELLIGENCE (AI) ANALYSIS
2.3.3. SOFTWARE
DEVELOPMENT
2.4. KEY
BUYING CRITERIA
2.4.1. APPLICATION
2.4.2. TECHNOLOGY
2.4.3. INTEGRATION
WITH EXISTING INFRASTRUCTURE
2.5. REGULATORY
FRAMEWORK
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
LAUNCHES
2.6.3. COLLABORATIONS
2.7. MARKET
DRIVERS
2.7.1. ADOPTION
OF AI BEING SUPPORTED BY LARGE VOLUMES OF HEALTHCARE DATA
2.7.2. PERSONALIZED
MEDICINE IN TESTS FOR CLINICAL DECISION-MAKING
2.7.3. INCREASING
START-UPS IN AI AND MACHINE LEARNING
2.8. MARKET
CHALLENGES
2.8.1. COST
CONSTRAINTS AND A LOW RETURN ON INVESTMENT (ROI)
2.8.2. CHALLENGES
IN SUSTAINING DATA SECURITY
2.8.3. SLOW
ADOPTION OF AI-BASED TECHNOLOGIES
2.9. MARKET
OPPORTUNITIES
2.9.1. EXPANDING
APPLICATIONS OF AI IN THE HEALTHCARE INDUSTRY
2.9.2. RISING
DEMAND FOR AI IN DRUG DISCOVERY
2.9.3. STRONG
FOCUS ON THE DEVELOPMENT OF PRECISION MEDICINE AND PERSONALIZED DRUGS
2.9.4. AI
USED TO ESTABLISH A REAL-TIME MONITORING SYSTEM
2.10. ANALYST
PERSPECTIVE
3. LATIN
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY SOLUTION
3.1. SOFTWARE
3.2. SERVICES
3.3. HARDWARE
4. LATIN
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY TECHNOLOGY
4.1. NATURAL
LANGUAGE PROCESSING
4.2. QUERYING
METHOD
4.3. CONTEXT
AWARE PROCESSING
4.4. DEEP
LEARNING
5. LATIN
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY TYPE
5.1. ROBOT-ASSISTED
SURGERY
5.2. VIRTUAL
NURSING ASSISTANT
5.3. ADMINISTRATIVE
WORKFLOW ASSISTANCE
5.4. FRAUD
DETECTION
5.5. DOSAGE
ERROR REDUCTION
5.6. CLINICAL
TRIAL PARTICIPANT IDENTIFIER
5.7. PRELIMINARY
DIAGNOSIS
5.8. OTHER
APPLICATIONS
6. LATIN
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET - BY INDUSTRY
VERTICAL
6.1. HEALTHCARE
PROVIDERS
6.2. PHARMACEUTICAL
AND BIOTECHNOLOGY COMPANIES
6.3. PAYERS
6.4. ACOS
AND MCOS
6.5. PATIENTS
7. LATIN
AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET – BY COUNTRY OUTLOOK
7.1. BRAZIL
7.1.1. BRAZIL
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.2. MEXICO
7.2.1. MEXICO
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST & PROSPECTS
7.3. REST
OF LATIN AMERICA
7.3.1. REST
OF LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET FORECAST
& PROSPECTS
8. COMPETITIVE
LANDSCAPE
8.1. GE
HEALTHCARE
8.1.1. OVERVIEW
8.1.2. PRODUCT
LIST
8.1.3. KEY
STRENGTHS
8.1.4. KEY
CHALLENGES
8.2. GENERAL
VISION INC
8.2.1. OVERVIEW
8.2.2. PRODUCT
LIST
8.3. GOOGLE
LLC
8.3.1. OVERVIEW
8.3.2. PRODUCT
LIST
8.3.3. KEY
STRENGTHS
8.3.4. KEY
CHALLENGES
8.4. IBM
CORPORATION
8.4.1. OVERVIEW
8.4.2. PRODUCT
LIST
8.4.3. KEY
STRENGTHS
8.4.4. KEY
CHALLENGES
8.5. INTEL
CORPORATION
8.5.1. OVERVIEW
8.5.2. PRODUCT
LIST
8.5.3. KEY
STRENGTHS
8.5.4. KEY
CHALLENGES
8.6. KONINKLIJKE
PHILIPS NV
8.6.1. COMPANY
OVERVIEW
8.6.2. PRODUCTS
8.6.3. KEY
STRENGTHS
8.6.4. KEY
CHALLENGES
8.7. MEDTRONIC
PLC
8.7.1. COMPANY
OVERVIEW
8.7.2. PRODUCT
LIST
8.7.3. KEY
STRENGTHS
8.7.4. KEY
CHALLENGES
8.8. MICROSOFT
CORPORATION
8.8.1. COMPANY
OVERVIEW
8.8.2. PRODUCT
LIST
8.8.3. KEY
STRENGTHS
8.8.4. KEY
CHALLENGES
8.9. NVIDIA
CORPORATION
8.9.1. OVERVIEW
8.9.2. PRODUCT
LIST
8.9.3. KEY
STRENGTHS
8.9.4. KEY CHALLENGES
8.10. ONCORA
MEDICAL
8.10.1. OVERVIEW
8.10.2. PRODUCT
LIST
8.11. RECURSION
PHARMACEUTICALS INC
8.11.1. OVERVIEW
8.11.2. PRODUCTS
8.12. STRYKER
CORPORATION
8.12.1. OVERVIEW
8.12.2. PRODUCT
LIST
8.12.3. KEY
STRENGTHS
8.12.4. KEY
CHALLENGES
8.13. SIEMENS
HEALTHINEERS AG
8.13.1. OVERVIEW
8.13.2. PRODUCT
LIST
8.13.3. KEY
STRENGTHS
8.13.4. KEY
CHALLENGES
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK,
HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 2: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK, FORECAST
YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: LIST OF
COLLABORATIONS
TABLE 6: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY SOLUTION, 2024-2032 (IN $
MILLION)
TABLE 7: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TECHNOLOGY, 2024-2032 (IN
$ MILLION)
TABLE 8: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2024-2032 (IN $
MILLION)
TABLE 9: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY INDUSTRY VERTICAL,
2024-2032 (IN $ MILLION)
TABLE 10: LATIN AMERICA
ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY OUTLOOK,
2024-2032 (IN $ MILLION)
FIGURE
1: PORTER’S FIVE FORCES ANALYSIS
FIGURE
2: MARKET MATURITY ANALYSIS
FIGURE
3: VALUE CHAIN ANALYSIS
FIGURE
4: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
SOLUTION, 2023 & 2032 (IN %)
FIGURE
5: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
SOFTWARE, 2024-2032 (IN $ MILLION)
FIGURE
6: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
SERVICES, 2024-2032 (IN $ MILLION)
FIGURE
7: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE
8: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
TECHNOLOGY, 2023 & 2032 (IN %)
FIGURE
9: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY NATURAL
LANGUAGE PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE
10: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
QUERYING METHOD, 2024-2032 (IN $ MILLION)
FIGURE
11: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY CONTEXT
AWARE PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE
12: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DEEP
LEARNING, 2024-2032 (IN $ MILLION)
FIGURE
13: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY TYPE, 2023
& 2032 (IN %)
FIGURE
14: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
ROBOT-ASSISTED SURGERY, 2024-2032 (IN $ MILLION)
FIGURE
15: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY VIRTUAL
NURSING ASSISTANT, 2024-2032 (IN $ MILLION)
FIGURE
16: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
ADMINISTRATIVE WORKFLOW ASSISTANCE, 2024-2032 (IN $ MILLION)
FIGURE
17: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY FRAUD
DETECTION, 2024-2032 (IN $ MILLION)
FIGURE
18: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY DOSAGE
ERROR REDUCTION, 2024-2032 (IN $ MILLION)
FIGURE
19: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
CLINICAL TRIAL PARTICIPANT IDENTIFIER, 2024-2032 (IN $ MILLION)
FIGURE
20: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
PRELIMINARY DIAGNOSIS, 2024-2032 (IN $ MILLION)
FIGURE
21: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY OTHER TYPES,
2024-2032 (IN $ MILLION)
FIGURE
22: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE
23: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
HEALTHCARE PROVIDERS, 2024-2032 (IN $ MILLION)
FIGURE
24: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE
25: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY PAYERS,
2024-2032 (IN $ MILLION)
FIGURE
26: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY ACOS
AND MCOS, 2024-2032 (IN $ MILLION)
FIGURE
27: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY
PATIENTS, 2024-2032 (IN $ MILLION)
FIGURE
28: LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET, BY COUNTRY
OUTLOOK, 2023 & 2032 (IN %)
FIGURE
29: BRAZIL ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $
MILLION)
FIGURE
30: MEXICO ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET 2024-2032 (IN $
MILLION)
FIGURE
31: REST OF LATIN AMERICA ARTIFICIAL INTELLIGENCE (AI) IN HEALTHCARE MARKET
2024-2032 (IN $ MILLION)